ARS Pharmaceuticals, Inc. (SPRY)
8.615
-0.12
(-1.43%)
USD |
NASDAQ |
May 11, 16:00
8.615
0.00 (0.00%)
After-Hours: 19:46
ARS Pharmaceuticals Total Assets (Quarterly) : 327.65M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 434.57M |
| Heron Therapeutics, Inc. | 670.88M |
| Krystal Biotech, Inc. | 1.397B |
| Century Therapeutics, Inc. | 223.70M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 213.39M |
| Shareholders Equity (Quarterly) | 114.26M |
| Debt to Equity Ratio | 0.8486 |
| Current Ratio | 7.278 |
| Net Debt Paydown Yield | -1.67% |